Read + Share
Amedeo Smart
Independent Medical Education
Harbeck N, Burstein HJ, Hurvitz SA, Johnston S, et al. A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer. Cancer 2022;128 Suppl 11:2209-2223.PMID: 35536015
Email
LinkedIn
Facebook
Twitter
Privacy Policy